Check-Cap (MBAI) Gains from Sales and Divestitures (2023 - 2024)
Check-Cap's (MBAI) quarterly Gains from Sales and Divestitures came in at $351.0 in Q4 2024, down 94.24% year-on-year from $6092.0 in Q1 2024, and down 94.24% quarter-over-quarter from $6092.0 in Q4 2023.
Check-Cap (MBAI) Gains from Sales and Divestitures (2023 - 2024) Analysis & Trends
Check-Cap has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $351.0 for Q4 2024.
- Gains from Sales and Divestitures for Q4 2024 came in at $351.0, down 94.24% year-over-year; the trailing twelve-month figure through Dec 2024 was $351.0 (down 94.24% YoY), and the FY2024 annual result was $351.0, down 94.24% from the prior year.
- Gains from Sales and Divestitures came in at $351.0 for Q4 2024 at Check-Cap, down from $6092.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $6092.0 in Q4 2023 to a low of $351.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Check-Cap | 200.71 Mn | 200.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 351.00 |
| Dec 31, 2024 | 351.00 |
| Dec 31, 2023 | 6,092.00 |
| Dec 31, 2023 | 6,092.00 |